In the FDCP-MIX CML cell line model it was shown that BCR-ABL kinase activity not only regulates transcriptional activity but also enhances CCN3 secretion by the cells (McCallum et al. 2006). This evidence concerns the gene CCN3 and chronic myelogenous leukemia, BCR-ABL1 positive.